Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma
for Recurrent Multiple Myeloma
40 locations incl. Ames
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT06232044·Phase 1, Phase 2·Recruiting